U. S. Food and Drug Administration
Center for Food Safety and Applied Nutrition
September 30, 2002


Public Meeting: Assessing Acrylamide in the U.S. Food Supply

Major Components of FDA's Action Plan for Acrylamide

September 30, 2002

[Transcript of Dr. Canady's remarks]

Begin Presentation


Author: Richard Canady, PhD DABT


Table of Contents
  1. Major Components of FDA's Action Plan for Acrylamide
  2. FDA assessment after press release by Sweden last April
  3. Questions raised
  4. Important to keep in mind
  5. Overview of this presentation: Major components of the plan
  6. Testing foods: General issues
  7. 1. Testing foods: Methods development
  8. 1. Testing foods: Sampling plan development
  9. Testing foods: Overall level of sampling
  10. 1. Testing foods: Occurrence
  11. 1. Testing foods: Exposure
  12. Total Diet Study component of FDA's acrylamide action plan
  13. Collection Sequencing for TDS
  14. FDA's Occurrence Data: Status
  15. Recap: Testing for acrylamide
  16. 2. Acrylamide formation: Research and outreach
  1. 3. Toxicology: State of Knowledge
  2. FDA's National Center for Toxicological Research (NCTR) short-term studies
  3. FDA's National Center for Toxicological Research (NCTR) longer-term studies
  4. 3. Toxicology: Evaluation of noncancer endpoints
  5. 4. Education
  6. 5. Meetings and collaborative projects: FDA-sponsored
  7. 5. Meetings and collaborative projects: Consortia and symposia
  8. 5. Meetings and collaborative projects: International
  9. Recap: Overall Goal
  10. Interagency meeting on acrylamide toxicity/biomarker research
  11. Agencies participating
  12. Topics addressed
  13. Additional goals of the meeting
  14. Multiple collaborations and potential synergies identified
  15. Next steps
Download presentation source (PPT format)


Pesticides, Metals, Chemical Contaminants, & Natural Toxins
Foods Home   |   FDA Home   |   Search/Subject Index   |   Disclaimers & Privacy Policy   |   Accessibility/Help

Hypertext updated by las 2002-OCT-29